Regional Medical Director, Value and Access - East
Stoke Therapeutics
Summary
The Regional Medical Director, Value and Access is a senior, field-based Medical Affairs leader who develops and executes the regional medical value strategy and serves as a scientific and strategic partner to payers, pharmacy benefit managers (PBMs), integrated delivery networks (IDNs), accountable care organizations (ACOs), Medicaid stakeholders, health technology assessment (HTA) bodies, and other population-health decision-makers. The role leads unbiased scientific exchange, translates clinical, health-economic, and real-world evidence into decision-relevant value narratives, and shapes regional priorities that support formulary evaluation, coverage, reimbursement readiness, and patient access.
Job description
Position Purpose
The Regional Medical Director, Value and Access is a senior, field-based Medical Affairs leader who develops and executes the regional medical value strategy and serves as a scientific and strategic partner to payers, pharmacy benefit managers (PBMs), integrated delivery networks (IDNs), accountable care organizations (ACOs), Medicaid stakeholders, health technology assessment (HTA) bodies, and other population-health decision-makers. The role leads unbiased scientific exchange, translates clinical, health-economic, and real-world evidence into decision-relevant value narratives, and shapes regional priorities that support formulary evaluation, coverage, reimbursement readiness, and patient access.
Key Responsibilities
Scientific Engagement
- Develop and execute a regional stakeholder engagement plan aligned with medical, evidence, and corporate priorities.
- Build peer-to-peer scientific relationships with senior clinical and population-health leaders across national and regional health plans, PBMs, Medicaid organizations, IDNs, ACOs, employer coalitions, and HTA bodies.
- Serve as the senior scientific contact for complex payer and reimbursement questions, including pre-launch and launch engagements.
- Lead balanced, non-promotional exchange on disease state, clinical data, guidelines, safety and efficacy, comparative evidence, HEOR, RWE, and pipeline information where appropriate.
- Plan and run payer advisory boards and scientific forums, and ensure insights are captured and acted on.
- Represent Medical Affairs at regional and national payer meetings and external forums.
Evidence Communication
- Lead regional communication of the totality of evidence: efficacy, safety, comparative data, HEOR, quality of life, budget impact, epidemiology, and RWE.
- Develop and maintain payer-facing scientific materials, and evidence summaries through appropriate review processes.
- Translate complex evidence into clear, decision-relevant scientific narratives for sophisticated payer audiences.
- Keep resources current, rigorous, and aligned with stakeholder needs.
Medical Strategy & Insights
- Own the regional medical value plan and contribute to annual and lifecycle planning, prioritization, and resource allocation.
- Gather and synthesize actionable insights on unmet needs, evidence expectations, coverage and policy changes, treatment paradigms, and competitive dynamics.
- Escalate regional trends and strategic implications to Medical Affairs leadership and cross-functional governance.
- Translate insights into recommendations for medical strategy, evidence generation, clinical development, publications, market access, and education.
- Define and monitor regional Medical objectives, KPIs, and impact; adjust plans as needed.
- Contribute senior scientific judgment to portfolio, indication, and lifecycle decisions while preserving Medical Affairs independence.
Cross-Functional Leadership & Capability Building
- Provide regional leadership and strategic counsel across Medical Affairs, Field Market Access, HEOR/RWE, Clinical Development, Commercial (within compliance guidelines), Government Affairs, Patient Services, Regulatory, Policy, and Medical Information.
- Lead cross-functional workstreams for launch planning, payer evidence planning, advisory boards, congress strategy, and medical education.
- Influence priorities and resolve competing needs without direct authority.
- Coach and mentor colleagues; Senior Director incumbents may also lead teams, vendors, budgets, or enterprise initiatives.
- Inform regional resource allocation, manage assigned project budgets and external partners, and represent the regional perspective in US and global planning forums.
Evidence Generation
- Identify and prioritize payer-relevant evidence gaps.
- Partner with HEOR/RWE, Epidemiology, Clinical Development, and Market Access on evidence plans, research questions, endpoints, and dissemination.
- Initiate or lead rigorous payer research collaborations, pragmatic pilots, data partnerships, investigator-sponsored research, and RWE projects.
- Provide senior field input into protocol concepts, publication strategy, congress communications, and medical information resources.
- Evaluate emerging evidence and recommend changes to regional strategy and engagement.
Governance, Compliance & Operational Excellence
- Operate in accordance with all applicable laws, industry codes, company policies, and SOPs.
- Maintain clear separation between scientific exchange and promotion, and apply sound judgment in novel situations.
- Document and manage insights, engagements, research collaborations, materials, and transfers of value appropriately.
- Identify operational risks, drive continuous improvement, and contribute to scalable field medical value processes.
- Complete required training and reporting accurately and on time.
Requirements
- Advanced clinical or scientific degree in a relevant discipline.
- 10+ years of progressive experience in Medical Affairs, payer medical engagement, Market Access, HEOR/RWE, clinical development, managed care, or a related pharma/biotech function.
- Formal training or demonstrated expertise in health economics, outcomes research, population health, managed care, epidemiology, or health policy strongly preferred.
- Deep expertise in managed care, formulary and coverage decision-making, evidence-based medicine, clinical trial methodology, HEOR, outcomes research, epidemiology, and real-world evidence.
- Strategic ability to connect external stakeholder needs with portfolio, evidence-generation, access, and medical priorities.
- Executive-level scientific communication, facilitation, and presentation skills.
- Ability to critically appraise complex clinical and economic data, identify limitations, and articulate implications for population-health decisions.
- Strong business and financial acumen, including prioritization, resource allocation, project planning, and measurement of impact.
- Proven influence in matrixed organizations and ability to lead across functions, geographies, and levels without direct authority.
- Sound judgment in ambiguous, high-visibility, and compliance-sensitive situations.
- Strong coaching, mentoring, change leadership, and capability-building skills.
- Ability to use digital engagement, insight analytics, and customer relationship tools effectively.
Benefits
- Medical, Dental & Vision
- Life & Disability Insurance
- Paid Parental Leave
- 401(k) Matching
- Unlimited PTO
- Tuition Assistance
- ESPP
- Annual Bonus
- Equity Participation
Company overview
Stoke Therapeutics (Nasdaq: STOK) is a biotechnology company dedicated to developing novel RNA-based medicines for severe genetic diseases. Founded in 2014 and headquartered in Bedford, Massachusetts, the company employs its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach to create antisense oligonucleotides (ASOs) that selectively restore naturally-occurring protein levels. Stoke's innovative platform focuses on haploinsufficiency diseases where patients have approximately 50% of normal protein levels, primarily targeting conditions affecting the central nervous system and eyes. The company's lead investigational medicine, zorevunersen (STK-001), is currently in Phase 3 clinical trials for Dravet syndrome, a severe form of childhood epilepsy, and has demonstrated promising disease-modifying potential. Stoke also has preclinical programs including STK-002 for autosomal dominant optic atrophy. The company has established strategic collaborations with industry leaders like Biogen for Dravet syndrome development and Acadia Pharmaceuticals for neurodevelopmental disorders. With approximately 51-200 employees, Stoke Therapeutics represents a pioneering force in RNA medicine, aiming to address unmet medical needs in rare genetic diseases through its innovative protein restoration technology.